1. Introduction {#sec1-molecules-21-01352}
===============

Drug-induced anaphylactoid reactions are pretty common in the clinic. Many drugs, especially injectable drugs such as anesthetics, contrast agents, anti-cancer drugs and herbal injections can induce varying degrees of anaphylactoid reaction which could be lethal. Herbal injection is one of the typical treatment options in China which exhibit excellent curative effects on cardiovascular diseases, respiratory diseases and cancer \[[@B1-molecules-21-01352],[@B2-molecules-21-01352]\]. For example, Shuanghuanglian (SHL) injection is commonly used for the treatment of respiratory infections and has been one of the top selling herbal medicine products over the last decade. Yuxingcao (YXC) injection is an effective preparation for the treatment of respiratory diseases, gynecological inflammation and urinary tract infections. Although these herbal injections are widely used in clinical practice, the incidence of adverse reaction has increased in recent years \[[@B3-molecules-21-01352]\]. Amongst the adverse reactions to Chinese medicines over the past decade, about 55.6% were caused by herbal injections \[[@B4-molecules-21-01352]\]. Moreover, some Western medicine injections such as paclitaxel injections and levofloxacin injections can also cause anaphylactoid reactions \[[@B5-molecules-21-01352],[@B6-molecules-21-01352]\]. Based on spontaneous adverse events reported by the US FDA, the incidence of anaphylactiod reaction after ciprofloxacin exposure has been estimated at 1.2 per 100,000 prescriptions in the United States \[[@B7-molecules-21-01352]\].

It has long been believed that the adverse reactions of herbal injections were caused by anaphylaxis \[[@B8-molecules-21-01352]\]. Anaphylaxis is a type I hypersensitivity reaction which occurs in response to encountered allergens. In this type of reaction, a sensitization and a triggering phase are distinguished. In the sensitization phase allergens are presented by dedicated antigen-presenting cells to Th2 lymphocytes, which then interact with B cells, antibody-producing lymphocytes, and help them in antibody switching and to produce allergen-specific IgE antibodies \[[@B9-molecules-21-01352],[@B10-molecules-21-01352]\]. Secreted specific IgE circulates in the blood and binds to an IgE-specific receptor (to the high affinity receptor, called FcεRI) on the surface of other kinds of immune cells such as basophils and mast cells. These immune cells are both involved in the acute inflammatory response \[[@B11-molecules-21-01352],[@B12-molecules-21-01352]\]. These allergen-specific IgE-bearing cells are now sensitized against the allergen and may trigger an allergic reaction upon the next contact with the allergen if at least 2 IgE antibodies on mast cells are bound to the allergen at the same time, a phenomenon called "bridging", that leads to an allergen-specific mast cell degranulation and histamine release. However, most adverse reactions of herbal injections occur at first administration and are closely associated with the dosage. All these characteristics coincide with anaphylactoid reactions. At present, it is believed that there are two ways to cause anaphylactoid reactions: one is induced by the direct stimulation of mast cells or basophils; the other is caused by the activation of the complement system \[[@B13-molecules-21-01352],[@B14-molecules-21-01352],[@B15-molecules-21-01352]\]. Stimulation of target cells induces anaphylactoid reactions by directly stimulating the G protein, which is a cellular protein involved in transmitting signals from a variety of stimuli outside a cell to its interior. Then a series of enzymes are activated leading to an increase in free calcium in the cytoplasm, inducing the degranulation of target cells and release of histamine and other mediators. In recent years, the complement system, especially the anaphylatoxins C3a and C5a was demonstrated to be involved in the pathogenetic mechanism of allergic diseases \[[@B16-molecules-21-01352],[@B17-molecules-21-01352]\]. The anaphylatoxins C3a and C5a are generated immediately by the complement system when a sensitizing drug gets into the body. The C5a anaphylatoxin could induce mast cell degranulation and release of thromboxane A2 after binding to the surface receptors of mast cells. Then a series of allergic symptoms occur. In this process, the total complement activity is decreased while the content of terminal complement complex SC5b-9 is increased \[[@B18-molecules-21-01352],[@B19-molecules-21-01352]\].

The initial presentation of anaphylactoid, allergic and inflammatory reactions is similar, and it is hard to differentiate anaphylactoid reactions from allergic reactions and sometimes even from inflammatory reactions simply based on their clinical presentation ([Table 1](#molecules-21-01352-t001){ref-type="table"}). This can lead to clinical misdiagnosis and an enormous threat to the patient's life. Therefore, it is very necessary to establish a practical and reliable method to diagnose anaphylactoid reactions quickly and accurately. In response to this need, in this study we use different animal models and injectable drugs to evaluate the expression of some representative physiological indexes in order to find the differences between anaphylactoid reactions, allergic reactions and inflammatory reactions.

2. Results {#sec2-molecules-21-01352}
==========

2.1. Anaphylactoid Reactions Provoked in Different Ways {#sec2dot1-molecules-21-01352}
-------------------------------------------------------

Guinea pig and nude rat is usually utilized as the model animals in immunology studies, so in the present study, they were stimulated by compound 48/80 (C48/80) for different times (15 min, 30 min and 60 min), and the resulting 5-HT level in plasma was determined by HPLC analysis ([Figure 1](#molecules-21-01352-f001){ref-type="fig"}).

As shown in [Figure 2](#molecules-21-01352-f002){ref-type="fig"}, the content of 5-HT in guinea pigs' plasma was significant higher than in nude rat (*p* \< 0.05). Therefore, guinea pig was chosen as the preferable animal model in the following research. For the purpose of investigating the optimized mode and time of stimulation, guinea pigs were treated with C48/80 through intramuscular injection (IM), intravenous injection (IV) and intraperitoneal injection (IP) for different times (15 min, 30 min and 60 min), respectively. As shown in [Figure 3](#molecules-21-01352-f003){ref-type="fig"}, the 5-HT levels of guinea pigs treated by IV were much higher than the other two modes (*p* \< 0.05). Moreover, the results indicated that 30 min was the most appropriate stimulation time.

2.2. Selection of Physiological Index {#sec2dot2-molecules-21-01352}
-------------------------------------

It is well known that C48/80, ovalbumin (OVA) and endotoxin (LPS) can induce anaphylactoid reactions, allergic reactions and inflammatory reactions, respectively \[[@B20-molecules-21-01352],[@B21-molecules-21-01352]\].

In order to distinguish these three pathological reactions, guinea pigs were stimulated by these three agents through IV and normal saline was used as the control. Blood samples were collected 30 min after treatment for the determination of some representative indicators of the three reactions (SC5b-9, 5-HT, Bb, C4d, histamine, C3a and IL-6).

As shown in [Figure 4](#molecules-21-01352-f004){ref-type="fig"}, OVA could significantly increase 5-HT and IL-6 production. C48/80 could promote the secretion of 5-HT, SC5b-9 and Bb, while LPS administration resulted in increases of IL-6, SC5b-9 and C4d. In addition, the levels of C3a and histamine were significantly increased in all reactions. Therefore, five of the seven indicators including SC5b-9, 5-HT, Bb, C4d and IL-6 were chosen as the physiological indexes to distinguish between these three reactions. Changes of the investigated indicators are shown in [Table 2](#molecules-21-01352-t002){ref-type="table"}. To distinguish between an anaphylactoid reaction and an allergic reaction, SC5b-9, IL-6, and Bb could be suitable indicators, while 5-HT, IL-6, Bb and C4d could be utilized to differentiate between anaphylactoid reactions and inflammatory reactions.

2.3. Measurement of Endotoxin in Each Injection {#sec2dot3-molecules-21-01352}
-----------------------------------------------

The dynamic turbidity method was performed using *Limulus* amebocyte lysate, an aqueous extract of blood cells from *Limulus polyphemus*, for the detection and quantification of endotoxin in SHL injection, YXC injection, paclitaxel injection, levofloxacin injection, diammonium glycyrrhizinate injection (negative control), toad venom injection and amiodarone hydrochloride injection. The detection range of *Limulus* amebocyte lysate is 0.01--10 EU/mL. As shown in [Table 3](#molecules-21-01352-t003){ref-type="table"}, the content of endotoxin in each injection is far lower than the limit value.

2.4. Anaphylactoid Reaction Provoked by SHL Injection, YXC Injection, Paclitaxel Injection, Levofloxacin Injection and Diammonium Glycyrrhizinate Injection {#sec2dot4-molecules-21-01352}
-----------------------------------------------------------------------------------------------------------------------------------------------------------

Guinea pigs were treated with different concentrations of SHL injection, YXC injection, paclitaxel injection, levofloxacin injection and diammonium glycyrrhizinate injection, respectively. The content of 5-HT, SC5b-9 and Bb in plasma increased in a dose-dependent manner, while the production of IL-6 and C4d showed no significant increase, which indicated that both of SHL injection and YXC injection could cause anaphylactoid reactions ([Figure 5](#molecules-21-01352-f005){ref-type="fig"}) as well as the paclitaxel injection and levofloxacin injection which also caused the rise of 5-HT, SC5b-9 and Bb in plasma ([Figure 6](#molecules-21-01352-f006){ref-type="fig"}).

However, none of the five humoral factors increased significantly in the diammonium glycyrrhizinate injection groups ([Figure 6](#molecules-21-01352-f006){ref-type="fig"}). These results are consistent with clinical reports.

2.5. Inflammatory Reaction Provoked by Amiodarone Hydrochloride Injection and Toad Venom Injection {#sec2dot5-molecules-21-01352}
--------------------------------------------------------------------------------------------------

There are some reports about inflammatory reactions caused by amiodarone hydrochloride injection and toad venom injection \[[@B22-molecules-21-01352],[@B23-molecules-21-01352]\], so they were also utilized to stimulate the guinea pigs in this study. As expected, both of them induced significant rises of SC5b-9, IL-6 and C4d levels ([Figure 7](#molecules-21-01352-f007){ref-type="fig"}).

3. Discussion {#sec3-molecules-21-01352}
=============

The anaphylactoid reaction presents with the same pathologic conditions and symptoms as the classical anaphylactic reaction and this affects the patient history gathering process, which may have a greater impact later on as a result. The clinical features of anaphylactoid, allergic and inflammatory reactions are similar. All of them can cause many autoimmune symptoms like spastic cough, conjunctivitis, urticaria and so on \[[@B24-molecules-21-01352],[@B25-molecules-21-01352]\]. Although anaphylactoid reactions occur at the first contact while allergic reactions need generally a number of previous contacts to develop, it is impossible to differentiate them if the patients cannot provide a clear case history. So far, there is no reliable method to differentiate anaphylactoid reactions from allergic reactions or inflammatory reactions.

In this study, we have established a feasible method for the prediction of the anaphylactoid reactions to injectable drugs and differentiate them from allergic or inflammatory reactions by screening an animal model, optimizing the mode of drug administration and optimal selection of physiologic indexes. Two well-known herbal injections and two Western medicine injections which were reported to be allergenic were tested to verify this method. Diammonium glycyrrhizinate injection was also used as the negative control. The result showed that this method could distinguish between the anaphylactoid, allergic and inflammatory reactions of injectable drugs.

Compound 48/80 is a polymer produced by the condensation of *N*-methyl-*p*-methoxy-phenethylamine with formaldehyde. It promotes histamine release and is usually utilized to induce mast cell degranulation in biochemical research \[[@B14-molecules-21-01352],[@B26-molecules-21-01352],[@B27-molecules-21-01352],[@B28-molecules-21-01352]\]. OVA and LPS are also used as positive controls in research on allergic reactions and inflammatory reactions \[[@B29-molecules-21-01352],[@B30-molecules-21-01352]\]. In this study, compound 48/80, OVA and LPS were utilized as the positive drugs to induce anaphylactoid, allergic and inflammatory reactions, respectively. The results showed that the levels of 5-HT, SC5b-9, IL-6, Bb and C4d in guinea pigs' plasma exhibited different responses in these three reactions. In anaphylactoid reactions, the levels of 5-HT, SC5b-9 and Bb were, significantly increased, while IL-6 and C4d levels showed almost no change. SC5b-9 is the end product of the complement system activation, so the determination of SC5b-9 levels can directly reflect the activation of the complement system \[[@B31-molecules-21-01352]\]. Bb is the fragment of complement B factor after hydrolysis, which is a representative index of complement alternative pathway activation \[[@B32-molecules-21-01352]\]. Consequently, we believe that the anaphylactoid reaction is likely to be produced by activating the complement system through alternative pathway activation. Inflammatory reactions induced increases of IL-6, SC5b-9 and C4d. C4d is the hydrolysate of C4 which is a representative indicator of the classical complement activation pathway \[[@B33-molecules-21-01352]\]. The results indicated that both inflammatory reactions and anaphylactoid reactions can activate the complement system but through different pathways. In allergic reactions, 5-HT and IL-6 were found to be the apparently changed physiological indicators which were different from those of anaphylactoid reactions and inflammatory reactions. Therefore, we could distinguish anaphylactoid reactions, allergic reactions and inflammatory reactions by the combination of these five physiological index (5-HT, SC5b-9, IL-6, Bb and C4d) ([Table 1](#molecules-21-01352-t001){ref-type="table"}). Our findings suggest a possible way to evaluate the allergenicity of the injectable drugs which may improve the safety of the clinical use of injectable drugs.

4. Experimental Section {#sec4-molecules-21-01352}
=======================

4.1. Animals {#sec4dot1-molecules-21-01352}
------------

Male Hartley guinea pigs and nude rats (Crl: NIH-Foxn1 rnu) weighing 250--350 g were purchased from the Laboratory Animal Center at Nanjing University of Chinese Medicine. All the animals were housed with a 12 h light/dark cycle at 22 °C and 55% ± 5% relative humidity and had free access to food and water. Animal experiment protocols in this study were carried out according to the guidelines of the Animal Care Committee of Nanjing University of Chinese Medicine.

4.2. Reagents {#sec4dot2-molecules-21-01352}
-------------

Compound 48/80 (C48/80) was purchased from Sigma-Aldrich (St. Louis, MO, USA; batch number is 073M4050V). Ovalbumin (OVA, batch number is 026K5448) was also purchased from Sigma-Aldrich. Endotoxin in the OVA was determined by *Limulus* Amebocyte Lysate assay (Xiamen BioEndo Technology Co., Ltd., Xiamen, China) and the content was less than 1 EU/mg. Serotonin (5-HT) was purchased from Sigma. *Shuanghuanglian* injection (SHL injection) and *Yuxincao* injection (YXC injection) were purchased from Harbin Jumbo Pharmaceutical Co., Ltd. (Harbin, China). Guinea pig-IL6 Elisa Kit, Guinea Pig-Bb Elisa Kit, Guinea pig-C3a Elisa Kit, Guinea pig-histamine Elisa Kit, Guinea pig-C4d Elisa Kit and Guinea pig-SC5b-9 Elisa Kit were all purchased from Amyjet Scientific, Inc. (London, UK).

4.3. Anaphylactoid Reactions Provoked by Different Ways {#sec4dot3-molecules-21-01352}
-------------------------------------------------------

Animals were anesthetized with sodium pentobarbital through intraperitoneal injections (40 mg/kg). C48/80 was dissolved in normal saline at the concentration of 0.1 mg/mL. Guinea pigs and nude rats (*n* = 10/group) were stimulated by compound C48/80 (10 mg/kg) through intravenous injection. Blood sample A (1 mL) was collected 5 min before the stimulation through the carotid artery, and samples after the stimulation (blood sample B) were collected at different times (15 min, 30 min and 60 min). Guinea pigs were treated with C48/80 by three different ways: intramuscular injection, intravenous injection and intraperitoneal injection. The blood sample A and the blood sample B were collected through the animals' carotid artery and the samples after the stimulation were collected at different times (15, 30 and 60 min). The serum was obtained through centrifugation (4000 rpm, 5 min) for the analysis of 5-HT.

4.4. Anaphylactoid Reactions, Anaphylactic Reactions and Inflammatory Reactions Provoked by Different Drugs {#sec4dot4-molecules-21-01352}
-----------------------------------------------------------------------------------------------------------

The guinea pigs used for anaphylactic reaction were pre-sensitized 21 days ahead the experiment. They were exposed to OVA 0.5 mL each time, q.o.d. for a total of three administrations. Then thirty normal guinea pigs and ten pre-sensitized guinea pigs were divided into four groups (normal saline, C48/80, LPS and OVA). C48/80, OVA and LPS were dissolved in normal saline at the concentration of 0.1 mg/mL and the guinea pigs were stimulated by intravenous injection (10 mg/kg). Blood sample A was collected 5 min before the stimulation through the carotid artery, and the samples after the stimulation(sample B) were collected at 30 min. Serum were obtained through centrifugation (4000 rpm, 5 min) for measurement of SC5b-9, 5-HT, Bb, C4d, histamine, C3a and IL-6.

4.5. Measurement of SC5b-9, 5-HT, Bb, C4d, Histamine, C3a and IL-6 in Animals' Plasma {#sec4dot5-molecules-21-01352}
-------------------------------------------------------------------------------------

SC5b-9, Bb, C4d, histamine, C3a and IL-6 in the plasma samples were measured by enzyme-linked immunosorbent assay (ELISA) following the manufacturers' instructions. The rising rate of SC5b-9, 5-HT, Bb, C4d, histamine, C3a and IL-6 was calculated according to the following equation: $$Rising~rate\left( \text{\%} \right) = \frac{\left( {valueB - valueA} \right)}{valueA} \times 100\%$$ where *value B* is the amount of SC5b-9, 5-HT, Bb, C4d, histamine, C3a and IL-6 in blood sample B and *value A* is the amount of SC5b-9, 5-HT, Bb, C4d, histamine, C3a and IL-6 in blood sample A.

4.6. Measurement of Endotoxin in Different Injections {#sec4dot6-molecules-21-01352}
-----------------------------------------------------

The endotoxin test was performed by the turbidity method. Briefly, an endotoxin standard substance (140 EU/mL) was diluted to 2.0, 0.5, 0.125, and 0.03125 EU/mL. A 100 μL portion of each dilution was mixed with the same volume of *Limulus* amebocyte lysate. The reaction mixtures were incubated at 37 °C and the optical density (OD) was simultaneously monitored. The time required to reach a designated turbidity (OD: 0.02) of the reaction mixtures was measured by endotoxin detector.

Analyses of the serial samples were performed using the least squares method. The relationship between endotoxin concentration and reaction time is as follows: $$\log T = 2.9641 - 0.1837\log C$$ where *T* is the reaction time (s) and *C* is the endotoxin concentration (EU/mL). The related coefficient *r* = −0.9989.

4.7. Anaphylactoid Reactions Provoked by SHL Injection, YXC Injection, Paclitaxel Injection, Levofloxacin Injection and Diammonium Glycyrrhizinate Injection in Vivo {#sec4dot7-molecules-21-01352}
--------------------------------------------------------------------------------------------------------------------------------------------------------------------

One hundred and sixty guinea pigs were randomly divided into sixteen groups. Guinea pigs were stimulated with different concentrations of SHL injection (4%, 20%, 100%), YXC injection (4%, 20%, 100%), paclitaxel injection (4%, 20%, 100%), levofloxacin injection (4%, 20%, 100%) and diammonium glycyrrhizinate injection (4%, 20%, 100%). Control group was treated with normal saline. Blood A were collected 5 min before the stimulation through the animals' carotid artery, and the samples after the stimulation were collected at 30 min. Serum were obtained through centrifugation for the detection of SC5b-9, 5-HT, Bb, C4d and IL-6.

4.8. Inflammatory Reaction Provoked by Amiodarone Hydrochloride Injection and Toad Venom Injection {#sec4dot8-molecules-21-01352}
--------------------------------------------------------------------------------------------------

Seventy guinea pigs were randomly divided into seven groups. Guinea pigs were stimulated with different concentrations of amiodarone hydrochloride injection (4%, 20%, 100%), and toad venom injection (4%, 20%, 100%). Control group was treated with normal saline. Blood sample A (1 mL) were collected 5 min before the stimulation through the animals' carotid artery, and the samples after the stimulation were collected at 30 min. Serum were obtained through centrifugation for the detection of SC5b-9, 5-HT, Bb, C4d and IL-6.

4.9. Statistical Analysis {#sec4dot9-molecules-21-01352}
-------------------------

Results were presented as mean ± SD. Experiments were conducted separately at least three times. Data were analyzed by one way ANOVA. Tukey's multiple comparison test was made for multiple comparisons among all groups if overall *p* \< 0.05. Probability (*p* value) of \<0.05 was considered to be statistically significant.

5. Conclusions {#sec5-molecules-21-01352}
==============

In this study we have established a feasible method for the evaluation of the anaphylactoid reactions caused by injectable drugs. Such findings provide technical support for the treatment of the serious clinical adverse reactions of injectable drugs, and promote the normal development and use of injectable drugs.
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![The HPLC chromatogram of serotonin.](molecules-21-01352-g001){#molecules-21-01352-f001}

![Rising levels of serotonin in guinea pigs' and nude rats' plasma after treatment with saline and C48/80 for different times (15, 30 and 60 min). \*\* *p* \< 0.01 vs. Nude rats (15 min); **^\#^** *p* \< 0.05 vs. Nude rats (30 min); **^&^** *p* \< 0.01 vs. Nude rats (60 min); ^△△△^ *p* \< 0.01 vs. Control guinea pigs (*n* = 10).](molecules-21-01352-g002){#molecules-21-01352-f002}

![Rising levels of serotonin in guinea pig plasma after treatment in different ways (IM: intramuscular injection; IV: intravenous injection; IP: intraperitoneal injection). \*\* *p* \< 0.01, \*\*\* *p* \< 0.001 vs. IM control, **^\#^** *p* \< 0.05, **^\#\#^** *p* \< 0.01, **^\#\#\#^** *p* \< 0.001 vs. IV control, **^&&^** *p* \< 0.01 vs. IP control, **^@^** *p* \< 0.05 vs. IM, **\*** *p* \< 0.05 vs. IP group (*n* = 10).](molecules-21-01352-g003){#molecules-21-01352-f003}

![Rising rates of 5-HT, SC5b-9, IL-6, Bb, C4d, C3a and histamine in plasma after treated with C48/80, LPS and OVA. (**A**: 5-HT; **B**: SC5b-9; **C**: IL-6; **D**: Bb; **E**: C4d; **F**: C3a; **G**: histamine). \*\* *p* \< 0.01, \*\*\* *p* \< 0.001 vs. control (*n* = 10).](molecules-21-01352-g004){#molecules-21-01352-f004}

![The rising rates of 5-HT, SC5b-9, Bb, IL-6, and C4d in animals' plasmas after treating with different doses of SHL injection and YXC injection ((**A**): SHL injection; (**B**): YXC injection). \* *p* \< 0.05, \*\* *p* \< 0.01, \*\*\* *p* \< 0.001 vs. control; **^\#^** *p* \< 0.05, **^\#\#^** *p* \< 0.01, **^\#\#\#^** *p* \< 0.001 vs. control; **^&&^** *p* \< 0.01, **^&&&^** *p* \< 0.001 vs. control (*n* = 10).](molecules-21-01352-g005){#molecules-21-01352-f005}

###### 

The rising rates of 5-HT, SC5b-9, Bb, IL-6, and C4d in animals' plasmas after treating with different doses of paclitaxel injection, levofloxacin injection and diammonium glycyrrhizinate injection ((**A**): paclitaxel injection; (**B**): levofloxacin injection; (**C**): diammonium glycyrrhizinate injection). \*\* *p* \< 0.01, \*\*\* *p* \< 0.001 vs. control; **^\#\#^** *p* \< 0.01, **^\#\#\#^** *p* \< 0.001 vs. control; **^&^** *p* \< 0.05, **^&&&^** *p* \< 0.001 vs. control (*n* = 10).
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![The rising rates of 5-HT, SC5b-9, Bb, IL-6, and C4d in animals' plasmas after treating with different doses of amiodarone hydrochloride injection and toad venom injection ((**A**): amiodarone hydrochloride injection; (**B**): toad venom injection). \* *p* \< 0.05, \*\* *p* \< 0.01, \*\*\* *p* \< 0.001 vs. control; ^\#^ *p* \< 0.05, **^\#\#^** *p* \< 0.01, **^\#\#\#^** *p* \< 0.001 vs. control; **^&^** *p* \< 0.05, **^&&&^** *p* \< 0.001 vs. control (*n* = 10).](molecules-21-01352-g007){#molecules-21-01352-f007}

molecules-21-01352-t001_Table 1

###### 

Definitions and general features of different reactions.

  Name                                       Definitions                                                                                                                                                                                                                                              General Features
  ------------------------------------------ -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Hypersensitivity                           A state of altered reactivity where people react with an exaggerated immune response to a foreign agent. The term includes allergic and pseudo-allergic reactions, but sometimes it is also used synonymously with immune-mediated allergic reactions.   If it is used synonymously with true allergy, it requires a pre-sensitized (immune) state of the host. There are four basic types of allergic reactions: immediate hypersensitivity, cytotoxicity, immune-complex mediated reactions and delayed type hypersensitivity.
  Type-I allergy or immediate type allergy   A type of allergic reaction induced by binding of allergen specific IgE antibodies to its high affinity receptor on mast cells (MC) resulting in antigen/allergen specific MC degranulation in pre-sensitized persons.                                   The reaction starts quickly, may be strong and fade quickly. It manifests as allergic rhinoconjunctivitis, allergic asthma or generalized urticaria or other organ manifestations.
  Anaphylaxis                                Anaphylaxis is simply the maximum variant of type-I allergy with systemic manifestation.                                                                                                                                                                 Anaphylaxis may begin within minutes or even seconds of exposure, can progress rapidly to airway constriction, generalized urticaria, intestinal and cardiovascular involvement. Without acute treatment it may end lethally.
  Anaphylactoid reactions                    Anaphylactoid reactions have no immunologic background and occur in a more dose-depend manner but require some individual predisposition too.                                                                                                            The clinical symptoms are similar to type-I reaction and therefore difficult to differentiate from IgE mediated Type I reactions.
  Drug idiosyncrasy                          Idiosyncrasy is an individual drug induced non-immunologic reaction and applies to genetically inherited enzyme defects involved in drug metabolism.                                                                                                     Idiosyncratic reactions occur therefore also in pre-disposed persons and may have similar features to allergic reactions.

molecules-21-01352-t002_Table 2

###### 

Changes of SC5b-9, 5-HT, Bb, C4d, histamine, C3a and IL-6 in anaphylactoid, anaphylactic and inflammatory reactions.

  Humoral Factors   Anaphylactoid Reaction   Anaphylactic Reaction   Inflammatory Reaction
  ----------------- ------------------------ ----------------------- -----------------------
  5-HT              \+                       \+                      −
  SC5b-9            \+                       −                       \+
  IL-6              −                        \+                      \+
  Bb                \+                       −                       −
  C4d               −                        −                       \+
  C3a               \+                       \+                      \+
  histamine         \+                       \+                      \+

"+" significantly increase, "−" no significant increase.

molecules-21-01352-t003_Table 3

###### 

Endotoxin concentration in each injection.

  Sample Name                                 Reaction Time (s)   Coefficient of Variation (%)   Recovery (%)   Contained (EU/mL)
  ------------------------------------------- ------------------- ------------------------------ -------------- -------------------
  4% SHL injection                            2708                \-                             75.85          \<0.01
  2729                                                                                                          
  20% SHL injection                           2139                0.36                           114.34         0.0103
  2128                                                                                                          
  100% SHL injection                          1766                1.31                           132.60         0.0274
  1799                                                                                                          
  4% YXC injection                            2698                \-                             109.78         \<0.01
  2675                                                                                                          
  20% YXC injection                           2098                4.41                           75.85          0.0095
  2233                                                                                                          
  100% YXC injection                          1714                1.75                           114.34         0.0317
  1757                                                                                                          
  4% paclitaxel injection                     2757                \-                             120.69         \<0.01
  2729                                                                                                          
  20% paclitaxel injection                    2478                \-                             114.54         \<0.01
  2491                                                                                                          
  100% paclitaxel injection                   2209                1.68                           93.93          0.0091
  2157                                                                                                          
  4% levofloxacin injection                   2641                \-                             105.88         \<0.01
  2673                                                                                                          
  20% levofloxacin injection                  2765                \-                             84.25          \<0.01
  2770                                                                                                          
  100% levofloxacin injection                 2174                1.08                           117.77         0.0097
  2141                                                                                                          
  4% diammonium glycyrrhizinate injection     2575                \-                             77.06          \<0.01
  2589                                                                                                          
  20% diammonium glycyrrhizinate injection    2187                2.20                           78.62          0.0098
  2120                                                                                                          
  100% diammonium glycyrrhizinate injection   1944                2.22                           83.81          0.0157
  2006                                                                                                          
  4% toad venom injection                     1880                1.74                           109.76         0.0195
  1926                                                                                                          
  20% toad venom injection                    2029                3.37                           94.97          0.0162
  1934                                                                                                          
  100% toad venom injection                   2001                1.94                           85.83          0.0141
  2056                                                                                                          
  4% amiodarone hydrochloride injection       2209                1.98                           118.82         \<0.01
  2272                                                                                                          
  20% amiodarone hydrochloride injection      2019                2.46                           87.18          0.0133
  2090                                                                                                          
  100% amiodarone hydrochloride injection     2069                \-                             88.96          0.0097
  2329                                                                                                          
